FDA-Drug2013-04-10Class II
CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96
Teva Pharmaceuticals USA, Inc.
Hazard
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Sold states
NC
Affected count
3 boxes
Manufactured in
650 Cathill Rd, N/A, Sellersville, PA, United States
Products
CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-237-2013Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief